Raymond James Maintains Strong Buy on DexCom, Raises Price Target to $147
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has reaffirmed a Strong Buy rating on DexCom (NASDAQ:DXCM) and increased the price target from $131 to $147.
January 03, 2024 | 4:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James analyst Jayson Bedford has reaffirmed a Strong Buy rating on DexCom and increased the price target from $131 to $147.
The increase in DexCom's price target by a reputable analyst from Raymond James is a strong positive signal, suggesting higher future stock performance. This typically leads to increased investor confidence and can result in a short-term uptick in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100